Antiparasitic Activity and Essential Oil Chemical Analysis of the Piper Tuberculatum Jacq Fruit

authors:

avatar Valterlúcio dos Santos Sales a , avatar Álefe Brito Monteiro a , avatar Gyllyandeson de Araújo Delmondes a , avatar Emmily Petícia do Nascimento a , avatar Francisco Rodolpho Sobreira Dantas Nóbrega de Figuêiredo a , avatar Cristina Kelly de Souza Rodrigues a , avatar Josefa Fernanda Evangelista de Lacerda a , avatar Cícera Norma Fernandes a , avatar Maysa de Oliveira Barbosa a , avatar Adamo Xenofonte Brasil a , avatar Saulo Relison Tintino a , avatar Maria Celeste Vega Gomez b , avatar Cathia Coronel b , avatar Henrique Douglas Melo Coutinho a , avatar José Galberto Martins da Costa a , avatar Cícero Francisco Bezerra Felipe c , avatar Irwin Rose Alencar de Menezes a , avatar Marta Regina Kerntopf a , *

Department of Biological Chemistry, Regional University of Cariri, Crato, CE, Brazil.
Center for the Development of Scientific Research, Foundation Moisés Bertoni/Laboratories Diaz Gill, Asunción-Paraguay.
Department of Molecular Biology, Federal University of Paraíba, Paraíba, PB, Brazil.

how to cite: dos Santos Sales V, Monteiro Á B, Delmondes G D A, do Nascimento E P, Sobreira Dantas Nóbrega de Figuêiredo F R, et al. Antiparasitic Activity and Essential Oil Chemical Analysis of the Piper Tuberculatum Jacq Fruit. Iran J Pharm Res. 2018;17(1):e124733. https://doi.org/10.22037/ijpr.2018.2179.

Abstract

With the increase of neglected diseases such as leishmaniasis and Chagas disease, there was a need for the search for new therapeutic alternatives that reduce the harm caused by medicine available for treatment. Thus, this study was performed to investigate the antiparasitic activity of the essential oil from the fruits of Piper tuberculatum Jacq, against lines of Leishmania braziliensis (MHOM/CO/88/UA301), Leishmania infantum (MHOM/ES/92/BCN83) and Trypanosoma cruzi (LC-B5 clone). Before running protocols, an analysis of the chemical composition of essential oil was conducted, which presented monoterpenes and sesquiterpenes. As major constituents, β-pinene and α-pinene were identified. Regarding to antiparasitic activity, the essential oil had an EC50 values of 133.97 µg/mL and 143.59 µg/mL against variations promastigotes of L. infantum and L. braziliensis, respectively. As for trypanocidal activity, the oil showed EC50 value of 140.31 µg/mL against epimastigote form of T. cruzi. Moreover, it showed moderate cytotoxicity in fibroblasts with LC50 value of 204.71 µg/mL. The observed effect may be related to the presence of terpenes contained in the essential oil, since it has its antiparasitic activity proven in the literature.

Introduction

Leishmaniasis caused by protozoa of the Leishmania genus, one of the six infectious and parasitic diseases of major importance in the world, is endemic in 98 countries, present on four continents: Africa, America, Asia and Europe, with annual record of 1 million to 1.5 million cases (1). Every year about 2 million new cases are notified, having a high detection rate and ability to produce deformities (2).

This disease occurs in 12 countries in Latin America, 90% of cases occurring in Brazil, especially in the Northeast region. In the country, the disease is found throughout the Brazilian territory except for the Southern region. Over the last 10 years, the annual average is of 3,156 cases, with an incidence of 2/100,000 cases per inhabitant. It is most common in children under 10 years old, and proportionally males are most affected (2).

Another annoyance disease neglected is Chagas, which began millions of years ago as enzootic diseases of wild animals, and subsequently transmitted to human beings characterized as an anthropozoonosis. Chagas disease is caused by the protozoan T. cruzi, which has affected about 12 million people only in Latin America and 75 million people are likely to acquire it (3).

Pharmacotherapy for leishmaniasis treatment and Chagas disease is a little bit scarce (4). This is due to commercial disinterest reflected by the fact that the parasitic diseases mainly affect developing countries, where the population has low purchasing power, leading to a low yield for factories, because the drugs would have to be affordable (5).

Chemotherapy with pentavalent antimony is widely used, but it is not free of side effects, requiring parenteral administration, extensive treatment and the emergence of resistance, justifying the search for effective alternative drugs, where medicinal plants are highlighted growing (6, 7). Based on this reasoning, the World Health Organization (WHO) emphasizes the urgent need to develop new medicine for the prophylaxis of these diseases (8).

In popular medicine, some species of the Piper genus showed antiparasitic activity; therefore may be required for employment as an alternative therapy (6). In developed studies, many compounds derived from Piper species have proven their parasitic activities (4, 6). The Piper betle extract showed activity against promastigotes of Leishmania donovani (9), Piper chaba was effective against promastigotes of L. donovani varieties (10), Piper hispidum was effective against amastigote form of L. amazonensis (11), and the extracts and fractions of Piper ovatum showed activity against the promastigote and amastigote varieties of L. amazonensis (12). Extracts and fractions of Piper reginelli (Mic) DC. var pallescens (C. DC.) Yunck were effective against promastigote form of L. amazonensis (13).

In this way, it is believed that P. tuberculatum Jacq. has the potential to combat parasitic diseases, by their kinship degree with the above species. P. tuberculatum Jacq. is a Piperaceae of economic and medicinal importance, popularly known as “monkey pepper”, found in regions of the states: Amazonas, Rondônia, Pará, Maranhão, Piauí, Ceará, Paraíba, Pernambuco, Rio de Janeiro and Mato Grosso. It is used empirically as sedative antidote for snake venom (14) and in the treatment of stomach disorders (15).

In this study, the objective was to assess the possible anti-parasitic effect of the essential oil from the fruits of P. tuberculatum Jacq., against lines of L. braziliensis and L. infantum as well as T. cruzi, contributing to the search for therapeutic alternatives for these diseases.

Experimental

Plant material and obtaining the essential oil

The plant material (fruits of P. tuberculatum Jacq.) was collected at the farm Arajara in the city of Barbalha, State of Ceará, Brazil. The botanical identification was carried out by Professor Dr. Maria Arlene Pessoa da Silva and a voucher specimen was deposited in the Herbarium Caririense Dárdano de Andrade Lima - HCDAL of the Regional University of Cariri - URCA, cataloged under the registration number 10631.

Fresh fruits (3852 g) were subjected to hydrodistillation in a Clevenger type device. The material was weighed and placed in a glass flask, added distilled water and subjected to boiling for 2 h. At the end of that period, the extracted essential oil was treated with anhydrous sodium sulphate to eliminate the residual moisture.

Chemical analysis of the essential oil

Analysis of the chemical composition of the essential oil was performed by gas chromatography coupled to mass spectrometer (CG/EM Shimadzu model QP5050A) and provided with a capillary column DB-5HT of fused silica with 30 m long, 0.25 mm internal diameter, and film of 0.25 μm, with helium as carrier gas and flow 0.8 mL/min. The injector temperature was 250 °C and the detector temperature (or interface) was 200 °C. The column temperature was programmed from 35 °C to 180 °C at 4 °C/min and then 180 °C to 250 °C at 10 °C/min. The mass spectra were recorded from 30-450 m/z.

The individual components were identified by matching their mass spectra with 70 eV impact energy, with the data base using the library built through the spectrometer (Wiley, 229) and other two computers using the retention indices as a pre-selection (16, 17), as well as by visual comparison of fragmentation pattern with those reported in the literature (18, 19).

Cell lines used

For the in-vitro tests for T. cruzi, CL-B5 clone was used (20). The parasites stably transected with the gene for β-galactosidase of Escherichia coli (lacZ) were provided by Dr. F. Buckner through Commemorative Gorgas Institute (Panama). Epimastigotes forms were cultured at 28 °C in Liver Infusion Tryptose Broth (Difco, Detroit, MI) supplemented with 10% Fetal Bovine Serum (FBS) (Gibco, Carlsbad, CA), penicillin (Ern, SA, Barcelona, Spain) and streptomycin (Reig Jofr SA, Barcelona, Spain) as described by Le Senne et al., (21). The cells were collected for testing in the exponential phase of growth.

Culture of Leishmania spp. were obtained from the Health Science Research Institute, Asunción, Paraguay - IICS and identified by isoenzyme analysis. The maintenance of lines, forms of cultivation and isolation of promatigotas forms of Leishmania spp. followed procedures described by Roldos et al., (22). The inhibitory action of these promastigotes forms were performed using the L. braziliensis (MHOM / CO / 88 / UA301) and L. infantum lines (MHOM/ES/92/BCN83), cultured at 22 °C in Schneider’s Drosophila supplemented with 20% FBS.

Cytotoxicity assays used NCTC929 fibroblasts lines were grown in Minimal Essential Medium (Sigma). The culture medium was supplemented with heat inactivated FBS (10%), penicillin G (100 U/mL) and streptomycin (100 mg/mL). Cultures were maintained at 37 °C in a humidified atmosphere with 5% CO2. The viability of the lines was evaluated through the use of resazurin as a colorimetric method (23).

Reagents

The sodium resazurin was obtained from Sigma-Aldrich (St. Louis, MO) and stored at 4 °C protected from light and prepared with 1% phosphate buffer, pH 7 and filter sterilized before use. The red-β-D-galactopyranoside chlorophenol (CPRG, Roche, Indianapolis, IN) was dissolved in a solution of Triton X-100 0.9% (pH 7.4). Penicillin G (Ern, SA, Barcelona, Spain), streptomycin (Reig Jofré SA, Barcelona, Spain) and Dimethyl sulfoxide (DMSO) were also used.

Anti-epimastigote activity test

The test was performed in microplates with 96 cavities with cultures in exponential phase, as described by Vega et al., (24). The epimastigotes were inoculated at a concentration of 1 x 105 mL-1 in 200 μL of tryptose liver broth. The plates were then incubated with the drugs at concentrations of 100 and 500 μg/mL at 28 °C for 72 h. After this time, 50 μL of CPRG solution was added to achieve a final concentration of 200 μM. The plates were incubated for an additional period of 6 h at 37 °C and were subjected for visualization under 595 nm. Each experiment was carried out twice and independently, with each concentration triplicate tested in each experiment. The efficiency of each compound was estimated by calculating the percentage of anti-epimastigotes activity (EA%).

Anti-promastigote activity test

Cultures of promastigotes forms of L. braziliensis and L. infantum were grown to a concentration of 106 cells/mL and then transferred to the test. The compounds were dissolved in DMSO to the concentrations to be tested, and transferred to the microplates. Each assay was triplicate performed. The activity of the compounds was assessed after 72 h by direct counting of the cells after serial dilutions and compared to an untreated control.

Cytotoxicity test

NCTC929 fibroblasts were plated in microdilution plates of 96 cavities at a final concentration of 3 × 104 cells/cavity. The cells were cultured at 37 °C in atmosphere with 5% CO2. After that, the culture medium was removed and the compounds were added 200 μL, being carried out a new culture for 24 h. After this incubation, 20 μL of a 2 mM solution of Resazurin was added to each cavity. The plates were incubated for 3 h and the reduction of resazurin was determined by absorbance at dual wavelengths of 490 and 595 nm. The control value (blank) was subtracted.

Statistical analysis

To determine the LC50 and EC50 data, they were analyzed using PROBITOS software.

Results and Discussion

The use of essential oils in traditional medicine has grown over the years, based on their medicinal activities, such as bactericidal, fungicidal, virucidal, anti-inflammatory, antispasmodic effects, among others. Essential oils are derived from aromatic plants and consist of secondary metabolites (25). A pharmacological property reported in the literature, being used as an alternative in antiparasitic therapy, since the increase of resistant parasites to drugs available in the market, directing for the encouragement of the development of research, by the search for new therapeutic agents (7, 26).

In the investigation of chemical composition of essential oil P. tuberculatum (EOPT), 0.34% yield is observed, being possible to identify 98.97% of constituents as shown in Table 1. Out of these identified compounds, there was emphasis on the β-pinene (27.74%) and α-pinene (26.54%), major compounds.

Among the chemicals already identified in species of Piper, several terpenes have already been described in the literature (27). In chemical analysis of essential oil of Piper aduncum, Piper amalago, Piper arboreum, Piper cernuum, Piper hispidum, Piper regnelii, Piper submarginalum, Piper vicosanum e Pothomorphe umbellata, os principais monoterpenos encontrados foram α-pineno, β-pineno, espatulenol, E-cariofileno, óxido de cariofileno, germacreno D e limoneno (28).

Terpenes identified in EOPT are shown into two types, sesquiterpenes and monoterpenes. The major components are structural isomers, being able to differentiate toxicity and types of biological activity (29). Besides them, it was also detected β-caryophyllene, β-ocimene, myrcene, limonene and other constituents in minor amounts.

Table 1

Chemical composition of the essential oil of Piper tuberculatum Jacq

Components(%)TR (min)Kovats indices
TOTAL98.97
α-pinene26.5412.54939
Sabinene2.6514.67976
β-pinene27.7414.94980
Myrcene1.5515.53991
Limonene3.0217.861031
1,8-cineole1.4118.05991
β–ocimene12.4518.921040
α-terpineol0.8127.701189
α-copaene1.2938.551376
β-caryophyllene14.3841.131418
α-humulene1.2643.221455
Germacrene D1.0945.101480
Nerolidol0.9447.371534
Spathulenol1.0247.861576
Caryophyllene oxide2.8247.971581
Table 2

Antiparasitic and cytotoxicity activity of the essential oil of Piper tuberculatum

DrugConcentration (µg/mL)Cytotoxicity activity
Antiparasitic activity
%CTFLC50(µg/mL)T. cruzi(%AE)EC50(µg/mL)L. infantum(%AP)EC50(µg/mL)L. braziliensis(%AP)EC50(µg/mL)
EOPT1000100 204.7170.00140.31100133.97100143,59
50098.19 70.0010086.53
25082.17 70.4110071.70
1251.75 52.9650.5051.01
NIFU1--54.90.91----
0,5-45.6--
PENTA6.25----54.25.69--
3.125--15.5-
METRO2------1000.51
1---97.9

As their antiparasitic activity, EOPT caused death percentage of > 87% against the parasitic forms of L. infantum of the studied concentrations. Before the promastigote variation of L. infantum in the concentration of 125 μg/mL, it caused the death of 50.5% of parasites. The anti-promastigote percentage against L. braziliensis was > 77% in the tested concentrations. Furthermore, EOPT in the 125 μg/mL concentration caused a parasite death of 51%. Against T. cruzi, the essential oil had, overall, an activity of 65% where the 125 μg/mL concentration was effective in producing inhibition of 52.9% (Table 2).

In the cytotoxic activity, OEPT caused mortality of 1.75%, 87.12%, 98.19% and 100% of fibroblasts at concentrations of 125, 250, 500 and 1000 μg/mL. Concentration of 125 μg/mL showed a low toxicity when compared to other concentrations with a cytotoxic percentage of 1.75% (Table 2).

In the literature, many Piper species have been described with antiparasitic effect. This is the case of the essential oil of Piper bredermayeri, Piper cf. divaricatum, Piper. var brachypodom, which showed activity against epimastigote forms of T. cruzi and promastigotes of L. infantum (30). Piper auritum showed to be active against a variety of L. braziliensis promastigote (31), as well as the Piper claussenianum was effective against variety of L. amazonensis promastigote (32) and Piper malacophyllum was effective against T. cruzi and L. braziliensis (33).

Some chemical compounds such as propanoic acid, esters, lignans, amides and terpenes, probably are responsible for the effect anti-leshmanicidal already identified in Piper species (32, 34, 35 and 36).

Such compounds may be associated with the effects observed in this study, since the main constituent of α-pinene of P. bredermeyeri and P. cf. divaricatum, same genus species of P. tuberculatum Jacq, was considered responsible for the effect against epimastigotes and amastigotes of T. Cruzi and promastigotes of L. infantum. (30). Other studies that have investigated this monoterpene alone showed significant results, justifying the effect obtained when using EOPT rich in α pinene. In the study of Sobral-Souza et al., (37) the α-pinene in the concentration of 100 µg/mL was effective against strains of the parasite L. braziliensis, corroborating the results found in this article.

Other compounds in EOPT were also tested against Leishmania spp. strains. Limonene also present in EOPT showed an EC50 of 252.6 µM/mL against epimastigote and promastigote of L. braziliensis variations (38). In addition, Myrcene obtained from Cymbopogon citratus showed an EC50 of 164 µg/mL against cultures of promastigotes of L. infantum (39). Izumi (40) noted that β-caryophyllene was effective against species of Leishmania spp. showing a synergy when combined with copalic acid present in the essential oil of copaiba. This study helps to prove that the terpenes may have synergistic anti-parasitic activity, a finding that is quoted on some articles, though not proven.

Limonene in its isomeric forms was effective to reduce the number of strains of T. cruzi epimastigote where the R-limonene showed a lower EC50 than S-limonene, showing greater efficiency (41). The caryophyllene obtained an EC50 of 30 µg/mL and 100 µg/mL against epimastigote and promastigotes variations of T. cruzi and L. braziliensis respectively (42).

Essential oils did not obtain their widely action mechanisms elucidated. Probably its lipid solubility and its secondary constituents influence in their antiparasitic activity, since it allows entry into cell membranes regulating structures of different layers of phospholipids, causing cellular damage (25).

Some compounds derived from essential oils showed different mechanism of action. β-caryophyllene produced disorganization of kinetoplast, forming concentric membranous vacuoles, lipid peroxidation, and changes in cell membrane integrity (40). This same compound is present in EOPT, suggesting that these EOPT may also have mechanisms of action. Other terpenes such as citral, presented antiparasitic activity against promastigotes of L. amazonensis species by modifying the morphology and ultrastructure of the parasite, producing mitochondrial swelling, two flagella and exocytic projections of the flagellar bag (43). The linalool also present in terpenes class produced significant changes of mitochondrial cristae parasites (44).

For the treatment of some tropical diseases, medicinal plants have been shown to be a viable source in the search for new alternatives (31). Thus, this study showed that the essential oil obtained from the fruits of P. tuberculatum Jacq., had good antiparasitic potential, corroborating some data already described in the literature and that probably the major compounds are responsible for the observed effect. Nevertheless, it is necessary further testing in order to elucidate its mechanism of action.

Acknowledgements

References

  • 1.

    Domínguez-Carmona DB, Escalante-Erosa F, García-Sosa K, Ruiz-Pinell G, Gutierrez-Yapu D, Chan-Bacab MJ, Giménez-Turba A, Peña-Rodríguez LM. Antiprotozoal activity of betulinic acid derivatives. Phytomedicine. 2010;17:379-82. [PubMed ID: 19748254].

  • 2.

    Brasil Ministério da Saúde; Secretária de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Manual de Vigilância e controle da leishmaniose visceral/Ministério da Saúde, Secretaria de Vigilância em Saúde. 1 ed. Brasília: 5. Reimpr. Ministério da Saúde; 2014.

  • 3.

    Zingales B. Trypanossoma cruzi: Um parasita, dois parasitas ou vários parasitas da doença de chagas? Revista da Biologia. 2011;6:44-8.

  • 4.

    Flores N, Jiménez IA, Giménez A, Ruiz G, Gutiérrez D, Bourdy G, Bazzocchi IL. Benzoic acid derivatives from Piper species and their antiparasitic activity. J. Nat. Prod. 2008;71:1538-43. [PubMed ID: 18712933].

  • 5.

    Wink M. Medicinal plants: A source of antiparasitic secondary metabolites. Molecules. 2012;17:12771-91. [PubMed ID: 23114614].

  • 6.

    Flores N, Jiménez IA, Giménez A, Ruiz G, Gutiérrez D, Bourdy G, Bazzocchi IL. Antiparasitic activity of prenylated benzoic acid derivatives from Piper species. Phytochemistry. 2009;70:621-7. [PubMed ID: 19361822].

  • 7.

    Oliveira LFG, Gilbert B, Villas-Bôas GK. Oportunidades para inovação no tratamento da leishmaniose usando o potencial das plantas e produtos naturais como fontes de novos fármacos. Rev. Fitos. 2014;8:33-42.

  • 8.

    Getti G, Durgadoss O, Domínguez-Carmona D, Martin-Quintal Z, Peraza-Sanchez S, Peña-Rodriguez LM, Humber D. Leishmanicidal activity of Yucatecan medicinal plants on Leishmania species responsible for cutaneous leishmaniasis. J. Parasitol. 2009;95:456-60. [PubMed ID: 18771334].

  • 9.

    Misra P, Kumar A, Khare P, Gupta S, Kumar N, Dube A. Pro apoptotic effect of the landrace Bangla mahoba of Piper betle on Leishmania donovani may be due to the high content of eugenol. J. Med. Microbiol. 2009;58:1058-66. [PubMed ID: 19528177].

  • 10.

    Naz T, Mosaddik A, Rahman M, Muhammad I, Haque E, Cho SK. Antimicrobial, antileishmanial and cytotoxic compounds from Piper chaba. Nat. Prod. Res. 2012;26:979-86. [PubMed ID: 21834629].

  • 11.

    Ruiz C, Haddad M, Alban J, Bourdy G, Reatgui R, Castillo D, Sauvain M, Deharo E, Estevez Y, Arevalo J, Rojas R. Activity-guided isolation of antileishmanial compounds from Piper hispidum. Phytochem. Lett. 2011;4:363-6.

  • 12.

    Rodrigues-Silva D, Nakamura CV, Dias-Filho BP, Ueda-Nakamura T, Cortez LER, Cortez DAP. In-vitro antileishmanial activity of hydroalcoholic extract, fractions, and compounds isolated from leaves of Piper ovatum Vahl against Leishmania amazonensis. Acta Protozool. 2009;48:73-81.

  • 13.

    Nakamura CV, Santos AO, Vendrametto MC, Luize PS, Dias-Filho BP, Cortez DAG, Ueda-Nakamura T. Atividade antileishmania do extrato hidroalcoólico e de frações obtidas de folhas de Piper regnellii (Miq) C DC var pallescens (C DC) Yunck. Rev. Bras. Farmacogn. 2006;16:61-6.

  • 14.

    Araújo-Júnior JX, Chaves MCO, Cunha EVL, Gray AI. Cepharanone B from Piper tuberculatum. Biochem. Syst. Ecol. 1999;27:325-7.

  • 15.

    Chaves MCO, Oliveira AH, Santos BVO. Aristolactams from Piper marginatum Jacq. (Piperaceae). Biochem. Syst. Ecol. 2006;34:75-7.

  • 16.

    Alencar JW, Craveiro AA, Matos FJA. Kovats indices as a preselection routine in mass spectra library search of volatiles. J. Nat. Prod. 1984;47:890-2.

  • 17.

    Alencar JW, Craveiro AA, Matos FJA, Machado MIL. Kovats indices simulation in essential oils analysis. Quím. Nova. 1990;13:282-4.

  • 18.

    Stenhagen E, Abrahamson S. McLafferty FW. Registry of mass spectra data base. Government Printing Office. Washington DC; 1974.

  • 19.

    Adams RP. Identification of essential oil components by gas chromatography/mass spectrometry. Allured Publishing Corporation; 1995.

  • 20.

    Buckner FS, Verlinde CL, La-Flamme AC, Van Voorhis WC. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob. Agents Chemother. 1996;40:2592-7. [PubMed ID: 8913471].

  • 21.

    Le Senne A, Muelas-Serrano S, Fernández-Portillo C, Escario JA, Gómez-Barrio A. Biological characterization of a beta-galactosidase expressing clone of Trypanosoma cruzi CL strain. Mem. Inst. Oswaldo Cruz. 2002;97:1101-5. [PubMed ID: 12563473].

  • 22.

    Roldos V, Nakayama H, Rolón M, Montero-Torres A, Trucco F, Torres S, Vega C, Marrero-Ponce Y, Haguaburu V, Yaluff G, Gómez-Barrio A, Sanabria L, Ferreira ME, De-Arias AR, Pandolfi E. Activity of a hydrohybinenzyl bryophyte constituent against Leishmania spp and Trypanosoma cruzi: In-silico,in-vitro and in-vivo activity studies. Eur. J. Med. Chem. 2008;43:1797-807. [PubMed ID: 18192088].

  • 23.

    Rolón M, Seco E, Vega C, Nogal JJ, Escario JA, Gómez-Barrio A, Malpartida F. Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosoma cruzi. Int. J. Antimicrob. Agents. 2006;28:104-9. [PubMed ID: 16844353].

  • 24.

    Vega C, Rolón M, Martínez-Fernández AR, Escario JA, Gómez-Barrio A. A new pharmacological screening assay with Trypanosoma cruzi epimastigotas expressing beta-galactosidase. Parasitol. Res. 2005;95:296-8. [PubMed ID: 15682334].

  • 25.

    Bakalli F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils – A review. Food Chem. Toxicol. 2008;46:446-75. [PubMed ID: 17996351].

  • 26.

    Anthony JP, Fyfe L, Smith H. Plant active components – A resource for antiparasitic agents? Trends Parasitol. 2005;21:462-8. [PubMed ID: 16099722].

  • 27.

    Reigada JB. Chemical constituents from Piper marginatum Jacq (Piperaceae) – Antifungal activities and kinetic resolution of (RS)- marginatumol by Candida antarctica lipase (Novozym 435). Tetrahedron: Asymmetry. 2007;18:1054-8.

  • 28.

    Mesquita JMO, Cavaleiro C, Cunha AP, Lombard JA, Oliveira AB. Estudo comparativo dos óleos voláteis de algumas espécies de Piperaceae. Rev. Bras. Farmacogn. 2005;15:6-12.

  • 29.

    Tabanca N, Demirci B, Crockett SL, Baser KH, Wedge DE. Chemical composition and antifungal activity of Arnica longifolia, Aster hesperius, and Chrysothamnus nauseosus essential oils. J. Agric. Food Chem. 2007;55:8430-5. [PubMed ID: 17894463].

  • 30.

    Leal SM, Pino N, Stashenko EE, Martínez JR, Escobar P. Antiprotozoal activity of essential oils derived from Piper spp. grown in Colombia. J. Essent. Oil Res. 2013;25:512-9.

  • 31.

    Monzote L, García M, Montalvo AM, Scull R, Miranda M. Chemistry, cytotoxicity and antileishmanial activity of the essential oil from Piper auritum. Mem. Inst. Oswaldo Cruz. 2010;105:168-73. [PubMed ID: 20428676].

  • 32.

    Marques AM, Barreto ALS, Curvelo JAR, Romanos MTV, Soares RMA, Kaplan MAC. Antileishmanial activity of nerolidol-rich essential oil from Piper claussenianu. Rev. Bras. Farmacogn. 2011;21:908-14.

  • 33.

    Santos TG, Rebelo RA, Dalmarco EM, Guedes A, Gasper AL, Cruz AB, Schmit AP, Cruz RCB, Steindel M, Nunes RK. Composição química e avaliação da atividade antimicrobiana do óleo essencial das folhas de Piper malacophyllum (C Presl) C DC Quím. Nova. 2012;35:477-81.

  • 34.

    Cabanillas BJ, Le Lamerm AC, Castillo D, Arevalo J, Rojas R, Odonne G, Bourdy G, Moukarzel B, Sauvain M, Fabre N. Caffeic acid esters and lignans from Piper sanguineispicum. J. Nat. Prod. 2010;73:1884-90. [PubMed ID: 20954722].

  • 35.

    Ferreira MGPR, Kayano AM, Silva-Jardim I, Da-Silva TO, Zuliani JP, Facundo VA, Calderon LA, De-Almeida SA, Ciancaglini P, Stabeli RG. Antileishmanial activity of 3-(3,4,5-trimethoxyphenyl) propanoic acid purified from Amazonian Piper tuberculatum Jacq Piperaceae fruits. Rev. Bras. Farmacogn. 2010;20:1003-6.

  • 36.

    Ghosal S, Deb A, Mishra P, Vishwakarma R. Leishmanicidal compounds from the fruits of Piper longum. Planta Med. 2012;78:906-8. [PubMed ID: 22576441].

  • 37.

    Sobral-Souza CE, Leite NF, Brito DIV, Lavor AKLS, Alencar LBB, Albuquerque RS, Ferreira JVA, Freitas MA, Matias EFF, Andrade JC, Tintino SR, Morais-Braga MFB, Vega C, Coutinho HDM. Cytotoxic and antiparasitic in-vitro activities of α-pinene and carvacrol. Acta Toxicol. Argent. 2014;22:76-80.

  • 38.

    Arruda DC, Miguel DC, Yokoyama-Yasunaka JK, Katzin AM, Uliana SR. Inhibitory activity of limonene against Leishmania parasites in-vitro and in-vivo. Biomed. Pharmacother. 2009;63:643-9. [PubMed ID: 19321295].

  • 39.

    Machado M, Pires P, Dinis AM, Santos-Rosa M, Alves V, Salgueiro L, Cavaleiro C, Sousa MC. Monoterpenic aldehydes as potential anti-Leishmania agents: Activity of Cymbopogon citratus and citral on L infantum L tropica and L major. Exp. Parasitol. 2012;130:223-31. [PubMed ID: 22227102].

  • 40.

    Izumi E, Ueda-Nakamura T, Veiga FV, Pinto AC, Nakamura CV. Terpenes from Copaifera demonstrated in-vitro antiparasitic and synergic activity. J. Med. Chem. 2012;55:2994-3001. [PubMed ID: 22440015].

  • 41.

    Escobar P, Leal SM, Herrera LV, Martinez JR, Stashenko E. Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components. Mem. Inst. Oswaldo Cruz. 2010;105:184-90. [PubMed ID: 20428679].

  • 42.

    Leite NF, Sobral-Souza CE, Albuquerque RS, Brito DIV, Lavor AKLS, Alencar LBB, Tintino SR, Ferreira JVA, Figueredo FG, Lima LF, Cunha FAB, Pinho AI, Coutinho HDM. Atividade antiparasitária in-vitro e citotóxica de cariofileno e eugenol contra Trypanossoma cruzi e Leishmania brasiliensis. Rev. Cubana Plant. Med. 2013;18:522-8.

  • 43.

    Santin MR, Dos-Santos AO, Nakamura CV, Dias Filho BP, Ferreira IC, Ueda-Nakamura T. In-vitro activity of the essential oil of Cymbopogon citratus and its major component (citral) on Leishmania amazonensis. Parasitol. Res. 2009;105:1489-96. [PubMed ID: 19669793].

  • 44.

    Rosa MSS, Mendonça-Filho RR, Bizzo HR, De Almeida RIA, Soares RM, Souto-Padrón T, Alviano CS, Lopes AH. Antileishmanial activity of a linalool-rich essential oil from Croton ajucara. Antimicrob. Agents Chemother. 2003;47:1895-901. [PubMed ID: 12760864].